3-(Trifluoromethyl)benzyl chloride structure
|
Common Name | 3-(Trifluoromethyl)benzyl chloride | ||
|---|---|---|---|---|
| CAS Number | 705-29-3 | Molecular Weight | 194.581 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 179.1±35.0 °C at 760 mmHg | |
| Molecular Formula | C8H6ClF3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 48.9±0.0 °C | |
| Symbol |
GHS02, GHS05 |
Signal Word | Danger | |
| Name | 3-Chloromethyl-benzotrifluoride |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 179.1±35.0 °C at 760 mmHg |
| Molecular Formula | C8H6ClF3 |
| Molecular Weight | 194.581 |
| Flash Point | 48.9±0.0 °C |
| Exact Mass | 194.011017 |
| LogP | 3.06 |
| Vapour Pressure | 1.3±0.3 mmHg at 25°C |
| Index of Refraction | 1.457 |
| Storage condition | Flammables area |
| Symbol |
GHS02, GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H226-H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | C:Corrosive; |
| Risk Phrases | R10;R34 |
| Safety Phrases | S16-S26-S36/37/39-S45 |
| RIDADR | UN 2920 8/PG 2 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 29036990 |
|
~%
3-(Trifluoromet... CAS#:705-29-3 |
| Literature: Helvetica Chimica Acta, , vol. 54, p. 868 - 897 Journal of Organic Chemistry, , vol. 42, # 5 p. 868 - 871 |
|
~%
3-(Trifluoromet... CAS#:705-29-3 |
| Literature: Journal of Medicinal Chemistry, , vol. 42, # 6 p. 1007 - 1017 |
|
~%
3-(Trifluoromet... CAS#:705-29-3 |
| Literature: Helvetica Chimica Acta, , vol. 54, p. 868 - 897 Journal of Organic Chemistry, , vol. 42, # 5 p. 868 - 871 |
| Precursor 3 | |
|---|---|
| DownStream 8 | |
| HS Code | 2903999090 |
|---|---|
| Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
|
Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.
J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... |
|
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
|
|
Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Arch. Pharm. (Weinheim) 346(8) , 571-6, (2013) In the present paper, a novel series of dithiocarbamates was synthesized via the treatment of 4-(trifluoromethyl)benzyl chloride with appropriate sodium salts of N,N-disubstituted dithiocarbamic acids... |
| m-(Trifluoromethyl)benzyl Chloride |
| EINECS 211-884-4 |
| 1-(Chloromethyl)-3-(trifluoromethyl)benzene |
| 3-(Trifluoromethyl)benzyl chloride |
| Benzene, 1-(chloromethyl)-3-(trifluoromethyl)- |
| α'-Chloro-α,α,α-trifluoro-m-xylene |
| m-Xylene, α'-chloro-α,α,α-trifluoro- |
| MFCD00000908 |